17th Sep 2015 08:13
LONDON (Alliance News) - Pharmaceutical services company Clinigen Group PLC on Thursday said it has signed a strategic alliance deal with Cumberland Pharmaceuticals Inc, a US-based specialty pharmaceuticals company focused on hospital acute care.
Under the deal, Clinigen will support Cumberland on the development, marketing, promotion and distribution of its future products in the US market.
No financial details on the deal were disclosed.
"A key strategic initiative this year has been to develop our group's global distribution footprint. The US is a particular area of focus where we are looking to initiate a long-term strategic partnership and Cumberland was a natural fit as a partner," said Clinigen Chief Executive Peter George.
Clinigen shares were down 0.1% at 729.50 pence early Thursday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
CLIN.L